🔎 Trials Near Me

Home › Prostate Cancer › Missouri › Rolla

Prostate Cancer clinical trials in Rolla, MO

5 studies for Prostate Cancer are looking for participants at sites in and around Rolla (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Mercy Clinic-Rolla-Cancer and Hematology, Rolla
  • Phelps Health Delbert Day Cancer Institute, Rolla
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

RecruitingPhase 3
  • Mercy Clinic-Rolla-Cancer and Hematology, Rolla
  • Phelps Health Delbert Day Cancer Institute, Rolla
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05946213

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

RecruitingPhase 3
  • Mercy Clinic-Rolla-Cancer and Hematology, Rolla
  • Phelps Health Delbert Day Cancer Institute, Rolla
Ages 18 and older · Men · Updated Aug 19, 2026 · NCT04423211

CARE Tool Study Aim 3

Recruiting
  • Delbert Day Cancer Institute at Phelps Health, Rolla
Ages 18 and older · All sexes · Updated Jul 8, 2026 · NCT07296887

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

RecruitingPhase 3
  • Delbert Day Cancer Institute at PCRMC, Rolla
Ages 18 and older · Men · Updated Sep 11, 2025 · NCT03678025

About Prostate Cancer

Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.

More about Prostate Cancer on MedlinePlus

Prostate Cancer trials in other cities

Other studies in Rolla

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.